GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.70
+0.20 (1.60%)
Dec 31, 2025, 4:00 PM EST - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $787.77 million as of December 31, 2025. Its market cap has increased by 95.62% in one year.
Market Cap
787.77M
Enterprise Value
494.47M
1-Year Change
95.62%
Ranking
Category
Stock Price
$12.70
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $787.77M, a decrease of -2.54%. That is a compound annual growth rate of -0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.93B |
| Johnson & Johnson | 499.81B |
| AbbVie | 405.95B |
| UnitedHealth Group | 301.06B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.39B |
| Novo Nordisk | 227.80B |